Search
인용 및 참조 문헌 (1)
Invitrogen™
dNTP Mix (2.5 mM)
Invitrogen 2.5 mM dNTP (2'-deoxynucleoside 5'-triphosphate) Mix consists of a solution of all four nucleotides, dATP, dCTP, dGTP, and dTTP,자세히 알아보기
| 카탈로그 번호 | 수량 |
|---|---|
| R72501 | 1 mL |
카탈로그 번호 R72501
제품 가격(KRW)
231,000
Online offer
Ends: 31-Mar-2026
264,000할인액 33,000 (13%)
Each
수량:
1 mL
제품 가격(KRW)
231,000
Online offer
Ends: 31-Mar-2026
264,000할인액 33,000 (13%)
Each
Invitrogen 2.5 mM dNTP (2'-deoxynucleoside 5'-triphosphate) Mix consists of a solution of all four nucleotides, dATP, dCTP, dGTP, and dTTP, each at a concentration of 2.5 mM. It is supplied in purified water and neutralized to pH 8.0 with NaOH. 2.5 mM dNTP Mix is suitable for use in a wide variety of molecular applications.
Applications
• Traditional PCR
• Sequencing
• cDNA synthesis
• Nick translation
• TdT-tailing reactions
For Research Use Only. Not for use in diagnostic procedures.
사양
수량1 mL
배송 조건Dry Ice
농도2.5 mM
용도(애플리케이션)Standard PCR
형태Liquid
라벨 또는 염료Unlabeled
Unit SizeEach
구성 및 보관
dNTP Mix, 2.5 mM (2 x 500 μL)
Store at –20°C.
Store at –20°C.
인용 및 참조 문헌 (1)
인용 및 참조 문헌
Abstract
Molecular emergence of acute myeloid leukemia during treatment for acute lymphoblastic leukemia.
Journal:Proc Natl Acad Sci U S A
PubMed ID:11526240
Therapy-related acute myeloid leukemias (t-AML) with translocations of the MLL gene are associated with the use of topoisomerase II inhibitors. We established the emergence of the malignant clone in a child who developed t-AML with a t(11;19) (q23;p13.3) during treatment for acute lymphoblastic leukemia (ALL). The MLL-ENL and the reciprocal